Voyager Therapeutics, Inc.
VYGR
$4.15
$0.030.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -116.64M | -119.72M | -126.78M | -107.93M | -84.69M |
| Total Depreciation and Amortization | 3.98M | 4.06M | 4.02M | 4.22M | 4.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.29M | 16.83M | 15.94M | 14.46M | 15.87M |
| Change in Net Operating Assets | -31.62M | -33.63M | -9.91M | -24.40M | -47.70M |
| Cash from Operations | -127.99M | -132.47M | -116.73M | -113.65M | -111.97M |
| Capital Expenditure | -1.95M | -2.60M | -2.13M | -2.18M | -2.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.30M | 128.04M | 52.94M | 82.46M | 44.45M |
| Cash from Investing | 92.35M | 125.45M | 50.82M | 80.28M | 42.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.07M | 816.00K | 1.25M | 1.18M | 1.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.07M | 816.00K | 1.25M | 1.18M | 1.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.58M | -6.21M | -64.66M | -32.19M | -68.32M |